02-14-2019 11:36 AM CET - Business, Economy, Finances, Banking & Insurance
Print

Kidney Cancer Diagnostics Market 2018-2028 Shares, Trend and Growth Report

Press release from: Fact.MR
PR Agency: Fact.MR
Kidney Cancer Diagnostics
Kidney Cancer Diagnostics
A new report published by Fact.MR estimates the global kidney cancer diagnostics market to exhibit an impressive expansion at during the forecast period 2017 to 2022. In terms of revenues, the global market for kidney cancer diagnostics will reach nearly US$ 700 Mn by 2022-end.

Kidney cancer is a type of cancer which starts in kidney cells. Two major types of kidney cancer include transitional cell carcinoma (TCC) and renal cell carcinoma (RCC). Different types of kidney cancer get developed in different ways which imply different long-term outcomes. This cancer originates in two principal locations of the kidney – the renal pelvis and the renal tubule.

Competition Tracking

Myriad Genetics Inc, NeoGenomics Laboratories, NanoString Technologies Inc., Sysmex Corporation, Rosetta Genomics, Illumina, Inc., Quest Diagnostics Incorporated, Roche Holding AG, Thermo Fisher Scientific Inc., and Abbott Laboratories are observed as key players in the global market for kidney cancer diagnostics.

Request Sample Report @ www.factmr.com/connectus/sample?flag=S&rep_id=56

Targeted Systemic Therapies for Metastatic Kidney Cancer are Providing Significant Benefits to Survival and Progression

Over the past few years, the diagnosis and management of kidney cancer, or, renal cell carcinoma (RCC), have undergone tremendous transformations. A number of discoveries, studies, and trails are being taken in renal mass biopsy, minimally-invasive thermal ablation, and active surveillance, owing to the surge in diagnosis rate of small renal masses, usually in patients with high morbidity risks related to operative treatment. In addition, targeted systemic therapies associated with metastatic kidney cancer have replaced cytokine-based treatment, providing significant benefits to survival and progression. Recent trails and reviews have cemented the partial nephrectomy’s role as the standard diagnosis-based surgical management option for majority of low-stage masses, and roles of adrenalectomy and lymphadenectomy pertaining to nephrectomy. These incidences are estimated to augment growth of the global kidney cancer diagnostics market.

Request/View Toc@ www.factmr.com/connectus/sample?flag=T&rep_id=56

Hospital-associated Labs will Remain Preferred for Kidney Cancer Diagnostics

On the basis of end-users, hospital-associated labs are estimated to remain preferred for kidney cancer diagnostics, accounting for the largest revenues by 2022-end. Independent diagnostic laboratories will continue to be the second most lucrative end-users in the global kidney cancer diagnostics market. In addition, cancer research institutes are expected to register the highest CAGR in the market through 2022.

Immunochemistry tests will continue to be sought-after for kidney cancer diagnostics, with revenues expected to reach US$ 351.8 Mn by 2022-end. This test type segment is projected to register the highest CAGR in the market through 2022, followed by complete blood count test.

Urine analysis will remain the second largest adopted tests for kidney cancer diagnostics across the globe. However, revenues from blood chemistry tests of kidney cancer diagnostics will continue to be lower as compared to rest of the test segments in the market.

North America to Remain the Largest Market for Kidney Cancer Diagnostics

In terms of revenues, North America is expected to remain the largest market for kidney cancer diagnostics, followed by Europe. However, kidney cancer diagnostics market in Europe will exhibit a comparatively higher CAGR than North America during the forecast period. In addition, Asia Pacific excluding Japan (APEJ) will continue to be the fastest expanding market for kidney cancer diagnostics through 2022.

Speak To Research Analyst for Detailed Insights @ www.factmr.com/connectus/sample?flag=AE&rep_id=56

Table of Content Covered in the report are:

Chapter 1 Global Kidney Cancer Diagnostics Market - Executive Summary 13

Chapter 2 Global Kidney Cancer Diagnostics Market Overview 15
2.1 Introduction 15
2.1.1 Global Kidney Cancer Diagnostics Market Taxonomy 15
2.1.2 Global Kidney Cancer Diagnostics Market Definition 15
2.2 Global Kidney Cancer Diagnostics Market Size (US$ Mn) and Forecast, 2012-2022 16
2.2.1 Global Kidney Cancer Diagnostics Market Y-o-Y Growth 16
2.3 Global Kidney Cancer Diagnostics Market Dynamics 16
2.3.1 Drivers 16
2.3.2 Restraints 17
2.3.3 Trends 17
2.4 Supply Chain 17
2.5 Epidemiology 17
2.6 List of Distributors 17
2.7 Average Pricing Analysis 18
2.8 Regulations 18
2.9 Key Participants Market Presence (Intensity Map) By Region 18

Access This Report @ www.factmr.com/checkout/56/S

Chapter 3 Global Kidney Cancer Diagnostics Market Analysis and Forecast By Test Type 19
3.1 Global Kidney Cancer Diagnostics Market Size and Forecast By Test Type, 2012-2022 19
3.1.1 Immunohistochemistry Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 19
3.1.1.1 Revenue (US$ Mn) Comparison, By Region 19
3.1.1.2 Market Share Comparison, By Region 21
3.1.1.3 Y-o-Y growth Comparison, By Region 21
3.1.2 Urine Analysis Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 22
3.1.2.1 Revenue (US$ Mn) Comparison, By Region 22
3.1.2.2 Market Share Comparison, By Region 24
3.1.2.3 Y-o-Y growth Comparison, By Region 24
3.1.3 Complete Blood Count Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 25
3.1.3.1 Revenue (US$ Mn) Comparison, By Region 25
3.1.3.2 Market Share Comparison, By Region 27
3.1.3.3 Y-o-Y growth Comparison, By Region 27
3.1.4 Blood Chemistry Test Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 28
3.1.4.1 Revenue (US$ Mn) Comparison, By Region 28
3.1.4.2 Market Share Comparison, By Region 30
3.1.4.3 Y-o-Y growth Comparison, By Region 30

Chapter 4 Global Kidney Cancer Diagnostics Market Analysis and Forecast By End User 32
4.1 Global Kidney Cancer Diagnostics Market Size and Forecast By End User, 2012-2022 32
4.1.1 Hospital Associated Labs Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 32
4.1.1.1 Revenue (US$ Mn) Comparison, By Region 32
4.1.1.2 Market Share Comparison, By Region 34
4.1.1.3 Y-o-Y growth Comparison, By Region 34
4.1.2 Independent Diagnostic Laboratories Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 35
4.1.2.1 Revenue (US$ Mn) Comparison, By Region 35
4.1.2.2 Market Share Comparison, By Region 37
4.1.2.3 Y-o-Y growth Comparison, By Region 37
4.1.3 Cancer Research Institutes Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 38
4.1.3.1 Revenue (US$ Mn) Comparison, By Region 38
4.1.3.2 Market Share Comparison, By Region 40
4.1.3.3 Y-o-Y growth Comparison, By Region 40
4.1.4 Others Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 41
4.1.4.1 Revenue (US$ Mn) Comparison, By Region 41
4.1.4.2 Market Share Comparison, By Region 43
4.1.4.3 Y-o-Y growth Comparison, By Region 43

Chapter 5 Global Kidney Cancer Diagnostics Market Analysis and Forecast By Indication 45
5.1 Global Kidney Cancer Diagnostics Market Size and Forecast By Indication, 2012-2022 45
5.1.1 Renal Cell Carcinoma Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 45
5.1.1.1 Revenue (US$ Mn) Comparison, By Region 45
5.1.1.2 Market Share Comparison, By Region 47
5.1.1.3 Y-o-Y growth Comparison, By Region 47
5.1.2 Transitional Cell Carcinoma Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 48
5.1.2.1 Revenue (US$ Mn) Comparison, By Region 48
5.1.2.2 Market Share Comparison, By Region 50
5.1.2.3 Y-o-Y growth Comparison, By Region 50
5.1.3 Wilms Tumor Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 51
5.1.3.1 Revenue (US$ Mn) Comparison, By Region 51
5.1.3.2 Market Share Comparison, By Region 53
5.1.3.3 Y-o-Y growth Comparison, By Region 53
5.1.4 Kidney Lymphoma Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 54
5.1.4.1 Revenue (US$ Mn) Comparison, By Region 54
5.1.4.2 Market Share Comparison, By Region 56
5.1.4.3 Y-o-Y growth Comparison, By Region 56
5.1.5 Kidney Sarcoma Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 57
5.1.5.1 Revenue (US$ Mn) Comparison, By Region 57
5.1.5.2 Market Share Comparison, By Region 59
5.1.5.3 Y-o-Y growth Comparison, By Region 59

Chapter 6 Global Kidney Cancer Diagnostics Market Analysis and Forecast By Region 61
6.1 Global Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 61
6.1.1 North America Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 61
6.1.1.1 Revenue (US$ Mn) Comparison, By Test Type 61
6.1.1.2 Revenue (US$ Mn) Comparison, By End User 63
6.1.1.3 Revenue (US$ Mn) Comparison, By Indication 65
6.1.2 Latin America Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 67
6.1.2.1 Revenue (US$ Mn) Comparison, By Test Type 67
6.1.2.2 Revenue (US$ Mn) Comparison, By End User 69
6.1.2.3 Revenue (US$ Mn) Comparison, By Indication 71
6.1.3 Europe Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 73
6.1.3.1 Revenue (US$ Mn) Comparison, By Test Type 73
6.1.3.2 Revenue (US$ Mn) Comparison, By End User 74
6.1.3.3 Revenue (US$ Mn) Comparison, By Indication 76
6.1.4 Japan Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 78
6.1.4.1 Revenue (US$ Mn) Comparison, By Test Type 78
6.1.4.2 Revenue (US$ Mn) Comparison, By End User 80
6.1.4.3 Revenue (US$ Mn) Comparison, By Indication 81
6.1.5 APEJ Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 83
6.1.5.1 Revenue (US$ Mn) Comparison, By Test Type 83
6.1.5.2 Revenue (US$ Mn) Comparison, By End User 85
6.1.5.3 Revenue (US$ Mn) Comparison, By Indication 87
6.1.6 MEA Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 89
6.1.6.1 Revenue (US$ Mn) Comparison, By Test Type 89
6.1.6.2 Revenue (US$ Mn) Comparison, By End User 91
6.1.6.3 Revenue (US$ Mn) Comparison, By Indication 92

Chapter 7 North America Kidney Cancer Diagnostics Market Analysis and Forecast, By Country, 2012-2022 95
7.1 US Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 95
7.1.1 Revenue (US$ Mn) Comparison, By Test Type 95
7.1.2 Revenue (US$ Mn) Comparison, By End User 96
7.1.3 Revenue (US$ Mn) Comparison, By Indication 97
7.2 Canada Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 98
7.2.1 Revenue (US$ Mn) Comparison, By Test Type 98
7.2.2 Revenue (US$ Mn) Comparison, By End User 99
7.2.3 Revenue (US$ Mn) Comparison, By Indication 100

And Continue....

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: www.factmr.com/
Follow Us on Linkedin: www.linkedin.com/company/factmr/

This release was published on openPR.
News-ID: 1588219 • Views: 98
More releasesMore releases

You can edit or delete your press release here: